FDA & EMA Inspection Readiness
GxP Gateway’s strategic mock inspections and preparation protocols ensure your organization can navigate high-stakes audits with minimal findings. We transform regulatory pressure into operational confidence, bridging the gap between compliance theory and audit-room reality.
Pre-Approval Inspection (PAI) Strategy
We provide focused preparation for companies transitioning from late-stage clinical trials to commercial manufacturing, to include data integrity audits, CMC documentation alignment, and facility walk-through readiness checks.
483 & Warning Letter Remediation
We offer ongoing support to maintain inspection-ready status through periodic reviews and trend monitoring. We conduct annual product reviews, pharmacovigilance system audits, and regulatory update briefings.
Mock Inspection & Stress Testing
We orchestrate realistic simulations of FDA/EMA audits to identify hidden gaps in your facility, documentation, and staff responses.
Post-Market Compliance Oversight
We offer expert technical support to address inspection findings and implement corrective actions that satisfy regulatory bodies.